PamelaRDrullinskyMD

PubMed

• Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma.
  Clare Grieve, Ashlee Joseph, Pamela Drullinsky, Andrew D Zelenetz, Paul Hamlin, Anita Kumar> ;Leukemia & Lymphoma. 2024 Feb 1
• 3 citations
  Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consoli...
  Tsai, C., Yang, J., Shaverdian, N., Patel, J., Shepherd, A., Eng, J., Guttmann, D., Yeh, R., Gelblum, D., Namakydoust, A., Preeshagul, I., Modi, S., Seidman, A., Train...> ;Lancet. 2024 Jan 13
• 7 citations
  Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.
  Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross, Pedram Razavi, Shanu Modi, Neil M Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsk...> ;Breast Cancer Research and Treatment. 2022 Oct 1
• Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design.
  Anita Kumar, Carla Casulo, Erel Joffe, Craig Moskowitz, John Gerecitano, Alison Moskowitz, Anas Younes, Pamela Drullinsky, Esther Drill, Morgan Choma, Clare Grieve, As...> ;Leukemia & Lymphoma. 2022 Dec 1
• 10 citations
  Morphological and genomic characteristics of breast cancers occurring in individuals with Lynch Syndrome
  Christopher J Schwartz, Edaise M da Silva, Antonio Marra, Andrea Gazzo, Pier Selenica, Vikas Rai, Diana Mandelker, Fresia Pareja, Maksym Misyura, Timothy M. D'Alfonso,...> ;Clinical Cancer Research. 2021 Oct 19
• 9 citations
  Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.
  Caitlin Stewart, Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank, Paul A. Hamlin, Matthew J. Matasar, John F. Gerecitano, Pamela Dr...> ;Clinical Cancer Research. 2021 Oct 6
• 5 citations
  Prephase rituximab/prednisone therapy and aging-related, pro-inflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
  Richard J. Lin, Colette Owens, Esther Drill, Augustine Iannotta, Mayan Oliveros, Dylan L Schick, Ariela Noy, John F. Gerecitano, Pamela Drullinsky, Philip Caron, Anita...> ;Haematologica. 2021 Jul 22
• 26 citations
  Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
  Anita Kumar, Carla Casulo, Ranjana H. Advani, Elizabeth Budde, Paul M. Barr, Connie Lee Batlevi, Philip Caron, Louis S. Constine, S.V. Dandapani, Esther Drill, Pamela ...> ;Journal of Clinical Oncology. 2021 Apr 28
• 116 citations
  Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre...
  Hope S. Rugo, Florence Lerebours, Eva Ciruelos, Pamela Drullinsky, Manuel Ruiz-Borrego, Patrick Neven, Yeon Hee Park, Aleix Prat, Thomas Bachelot, Dejan Juric, Nichola...> ;The Lancet. Oncology. 2021 Apr 1
• 2 citations
  Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.
  Zachary D. Epstein-Peterson, Nivetha Ganesan, Juliet N. Barker, Pamela Drullinsky, Paola Ghione, Ann A. Jakubowski, Anita Kumar, Alison J. Moskowitz, Ariela Noy, Migue...> ;Leukemia & Lymphoma. 2021 Mar 29
• 79 citations
  Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER ...
  Susan Dent, J. Cortes, Yunjoo Im, Véronique Diéras, Nadia Harbeck, Ian E. Krop, Timothy R. Wilson, Na Cui, Frauke Schimmoller, J.Y. Hsu, Jing He, M. De Laurentiis, Sof...> ;Annals of Oncology. 2021 Feb 1
• 15 citations
  Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer
  Diana G Wang, Dulce M. Barrios, Victoria S. Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel Funt, Komal Jhaveri, Diana Lake, Tomas G. Lyons, Shanu Modi, Pedram...> ;Breast Cancer Research and Treatment. 2020 Jun 29
• 18 citations
  Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer
  Pamela Drullinsky, Sara A. Hurvitz> ;Breast Cancer Research and Treatment. 2020 Apr 9
• 16 citations
  Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
  Meghan Salcedo, Nikoletta Lendvai, Donna Mastey, Julia Schlossman, Malin Hultcrantz, Neha Korde, Sham Mailankody, Alexander M. Lesokhin, Hani Hassoun, Eric L. Smith, U...> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Mar 1
• 42 citations
  Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
  Sven Borchmann, Erel Joffe, Craig H. Moskowitz, Andrew D. Zelenetz, Ariela Noy, Carol S. Portlock, John F. Gerecitano, Connie Lee Batlevi, Philip Caron, Pamela Drullin...> ;Blood. 2019 May 16
• 46 citations
  A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
  Craig S. Sauter, Matthew J. Matasar, Heiko Schöder, Sean M. Devlin, Pamela Drullinsky, John F. Gerecitano, Anita Kumar, Ariela Noy, Maria Lia Palomba, Carol S. Portloc...> ;Blood. 2018 Apr 19
• 52 citations
  Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
  Anita Kumar, Carla Casulo, Joachim Yahalom, Heiko Schöder, Paul M. Barr, Philip Caron, April Chiu, Louis S. Constine, Pamela Drullinsky, Jonathan W. Friedberg, John F....> ;Blood. 2016 Sep 15
• 27 citations
  Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival...
  L.M. Smyth, Neil M. Iyengar, Melanie Chen, S. M. Popper, S. Patil, Carolyn Wasserheit-Lieblich, Daniel F. Argolo, Jasmeet Chadha Singh, Sarat Chandarlapaty, Steven Sug...> ;Breast Cancer Research and Treatment. 2016 Jun 15
• 1 citations
  A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
  Neil M. Iyengar, Monica Fornier, Steven Sugarman, Maria Theodoulou, Tiffany A. Troso-Sandoval, Gabriella D'Andrea, Pamela Drullinsky, Devika Gajria, Shari Goldfarb, El...> ;Clinical Breast Cancer. 2016 Apr 1
• 28 citations
  Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diff...
  David J. Straus, Paul A. Hamlin, Matthew J. Matasar, Maria Lia Palomba, Pamela Drullinsky, Andrew D. Zelenetz, John F. Gerecitano, Ariela Noy, Audrey Hamilton, Rebecca...> ;British Journal of Haematology. 2015 Mar 1
• 85 citations
  A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
  Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson, Shari Goldfarb, Pamela Drullinsky, Steven Sugarman, Carolyn Wasserheit-Leiblich, Julie...> ;Clinical Breast Cancer. 2014 Jun 1
• 13 citations
  Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myel...
  Heather Landau, Neeta Pandit-Taskar, Hani Hassoun, Adam D. Cohen, Alex Lesokhin, Nikoletta Lendvai, Pamela Drullinsky, Philip Schulman, Suresh C. Jhanwar, Elizabeth Ho...> ;Leukemia & Lymphoma. 2012 Feb 1
• 16 citations
  Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
  Devika Gajria, Joseph Gonzalez, Kimberly Feigin, Sujata Patil, Carol L. Chen, Maria Theodoulou, Pamela Drullinsky, Gabriella D'Andrea, Diana Lake, Larry Norton, Cliffo...> ;Breast Cancer Research and Treatment. 2012 Jan 1
• TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR- metastatic breast cancer (MBC).
  Gucalp A, Tolaney SM, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo HS, Nabell L, Abbruzzi A, Gonzalez J, Giri DD, Patil S, Feigin K, D'Andrea G, Theodoul...> ;J. Clin. Oncol.. 2011-05-20
• 4 citations
  Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
  Pamela Drullinsky, Steven Sugarman, Monica Fornier, Gabriella D'Andrea, Teresa Gilewski, Diana Lake, Tiffany A. Traina, Carolyn Wasserheit-Lieblich, Nancy Sklarin, Dee...> ;Clinical Breast Cancer. 2010 Dec 1
• Join now to see all

Abstracts/Posters

• A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
  Pamela Drullinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Pamela Drullinsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019